Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, will release its third quarter 2023...

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, today announced that Benoit Gourdier...

Board Will Accelerate Solutions for Life Sciences Customers; Includes Experts in Biologic Manufacturing Sciences and Technology, Chemistry and Gene Therapy RADNOR, Pa., Sept. 21, 2023 /PRNewswire/...

Partnership will satisfy growing need among biopharma and life science companies for end-to-end solutions so customers can focus on science RADNOR, Pa., Sept. 7, 2023 /PRNewswire/ -- Avantor, Inc....

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied...

Net sales of $1.74 billion, decrease of 8.7%; core organic decline of 6.5% Net income of ($7.3) million; Adjusted EBITDA of $343.0 million Diluted GAAP EPS of ($0.01); adjusted EPS of $0.28...